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In September 2015 the symposium entitled: 
Multidisciplinary approach to diagnostic, treat-
ment and monitoring of patients with ovarian 
cancer; potential of the HE4 and ROMA index, 
was held at the University Hospital for Tumors, 
Clinical Hospital Center Sestre milosrdnice.
Support in organization of the symposium we 
got from the Ministry of Health of Croatia, and it 
was also symbolic way of denoting September as 
the month dedicated to spreading awareness about 
ovarian cancer. This professional meeting has been 
supported by  the Croatian Medical Chamber. The 
symposium was primarily directed towards gyne-
cologists with the aim to get acquainted with avail-
ability for the new tumor mar ker HE4 and mathe-
matically calculated ROMA index, both useful in 
diagnostic and monitoring patients with ovarian 
tumor. Implementation of HE4 has started for the 
fi rst time in Croatia about a year and a half before 
the symposium was held in Department of Medical 
Biochemistry in University Hospital for Tumors, 
and it was also the opportunity to demonstrate our 
own results and expe rience. The introduction of 
new markers is the result of excellent communica-
tion and the willingness of doctors from the De-
partment of Gynecological Oncology who were the 
ones who recruited the patients. The implementa-
tion of new parameters itself in laboratory daily 
routine was done after completely fulfi lling all the 
segments of analytical validation and verifi cation 
procedures performed in accordance with recent 
CLSI guidelines.
The symposium was mutidisciplinary, be-
cause of the same topic (ovarian cancer) was elab-
orated by epidemiologist, gynecologist, patholo-
gist, cytologist, radiologist, biochemist, oncolo-
gist, pharmacist, each of them highlighting their 
individual specifi cs of their views to the above 
mentioned. Finally, clinical cases, with proofs of 
the advantages and disadvantages of the new 
markers summed up the points of the meeting.
The purpose of this event was to inform the tar-
geted professionals (gynecologists and medical 
biochemists in the laboratory) about diagnostic 
potential of the HE4 and ROMA index. As a result, 
the Croatian Health Insurance put HE4 at the ap-
proved list of tests.Taking into consideration often 
justifi ed skepticism of clinicians regarding the in-
troduction of permanently obtained new biomark-
ers, in this case we got a huge positive reaction. It 
is doubtless the result of the practical value of 
good correlation in laboratory results with clinical 
fi ndings, which is not the case with every marker.
We are sincerely grateful to all the speakers at the 
symposium, because all of them were unison in 
decision to transform their lectures into an article. 
The result is accesible in the following pages. We 
truly appreciate their eff ort and commitment. Fur-
thermore, we would like to express our gratitude 
for the support of  the Head of the University Hos-
pital for Tumors and the Director of the University 
Hospital Center Sestre milosrdnice professor 
Danko Velimir Vrdoljak for his support in orga-
nizing the symposium. We would also like to 
thank all the employees in Department of Medical 
Biochemistry in Oncology who took part in reali-
sation of this symposium.
